- Home
- ALGT vs KNSA Comparison
ALGT vs KNSA Comparison
Compare ALGT & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGT
- KNSA
- Stock Information
- Founded
- ALGT 1997
- KNSA 2015
- Country
- ALGT United States
- KNSA United Kingdom
- Employees
- ALGT N/A
- KNSA N/A
- Industry
- ALGT Air Freight/Delivery Services
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- ALGT Consumer Discretionary
- KNSA Health Care
- Exchange
- ALGT Nasdaq
- KNSA Nasdaq
- Market Cap
- ALGT 1.5B
- KNSA 1.3B
- IPO Year
- ALGT 2006
- KNSA 2018
- Fundamental
- Price
- ALGT $105.30
- KNSA $18.73
- Analyst Decision
- ALGT Hold
- KNSA Strong Buy
- Analyst Count
- ALGT 10
- KNSA 5
- Target Price
- ALGT $83.80
- KNSA $36.60
- AVG Volume (30 Days)
- ALGT 274.2K
- KNSA 469.7K
- Earning Date
- ALGT 02-04-2025
- KNSA 02-26-2025
- Dividend Yield
- ALGT 1.14%
- KNSA N/A
- EPS Growth
- ALGT N/A
- KNSA N/A
- EPS
- ALGT N/A
- KNSA N/A
- Revenue
- ALGT $2,495,886,000.00
- KNSA $384,098,000.00
- Revenue This Year
- ALGT $2.04
- KNSA $60.05
- Revenue Next Year
- ALGT $12.34
- KNSA $36.74
- P/E Ratio
- ALGT N/A
- KNSA N/A
- Revenue Growth
- ALGT N/A
- KNSA 54.41
- 52 Week Low
- ALGT $36.09
- KNSA $16.56
- 52 Week High
- ALGT $106.87
- KNSA $28.15
- Technical
- Relative Strength Index (RSI)
- ALGT 74.73
- KNSA 38.56
- Support Level
- ALGT $101.49
- KNSA $18.27
- Resistance Level
- ALGT $105.15
- KNSA $19.05
- Average True Range (ATR)
- ALGT 4.14
- KNSA 0.61
- MACD
- ALGT 0.36
- KNSA -0.05
- Stochastic Oscillator
- ALGT 91.27
- KNSA 34.42
About ALGT Allegiant Travel Company
Allegiant Travel Co provides travel services in the United States. It sells air transportation on a stand-alone basis or bundled with air-related and third-party services and products. Customers may also purchase fixed-fee flying arrangements to receive charter service on a year-round and ad hoc basis. Additionally, customers may purchase hotel rooms, ground transportation, and other attractions (for example, entertainment show tickets) to accommodate a trip. The company's operating segment includes Airline, Sunseeker Resort, and other non-airlines. Customers purchase travel tickets at airport ticket counters, online, or through its telephone reservation center.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.